iRhythm Holdings, Inc. IRTC
93.02 USD +4.34 (+4.89%)
Nov 12, 2026, 2:44 PM EST
88.47 Day range 94.63
82.85 52-week range 192.47
- YTD
- -47.58%
- 1 year
- -48.07%
News
globenewswire.com iRhythm Announces Approval of $200 Million Share Repurchase Program SAN FRANCISCO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and…
benzinga.com Stephens & Co. Maintains Overweight on iRhythm Holdings, Lowers Price Target to $120 Stephens & Co. analyst Mason Carrico maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $160 to $120.
benzinga.com Truist Securities Maintains Buy on iRhythm Holdings, Lowers Price Target to $140 Truist Securities analyst Richard Newitter maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $168 to $140.
benzinga.com Freedom Capital Markets Maintains Buy on iRhythm Holdings, Lowers Price Target to $159 Freedom Capital Markets analyst Gene Mannheimer maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $190 to $159.
prnewswire.com IRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC) A revenue shortfall against Wall Street consensus, flat Zio AT sales, and the Zio MCT FDA submission has now slipped into 2027. SueWallSt notifies investors of a pending investigation into potential…
benzinga.com Citigroup Downgrades iRhythm Holdings to Neutral, Lowers Price Target to $124 Citigroup analyst Joanne Wuensch downgrades iRhythm Holdings (NASDAQ:IRTC) from Buy to Neutral and lowers the price target from $157 to $124.
benzinga.com Canaccord Genuity Maintains Buy on iRhythm Holdings, Raises Price Target to $206 Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the price target from $196 to $206.- benzinga.com Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $135 Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $150 to $135.
benzinga.com Evercore ISI Group Maintains Outperform on iRhythm Holdings, Lowers Price Target to $140 Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and lowers the price target from $150 to $140.
benzinga.com Piper Sandler Maintains Overweight on iRhythm Holdings, Lowers Price Target to $150 Piper Sandler analyst Adam Maeder maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $160 to $150.
globenewswire.com iRhythm Holdings to Participate in Upcoming Investor Conferences SAN FRANCISCO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and…- benzinga.com Needham Maintains Buy on iRhythm Holdings, Lowers Price Target to $165 Needham analyst David Saxon maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $194 to $165.
- benzinga.com BTIG Maintains Buy on iRhythm Holdings, Lowers Price Target to $170 BTIG analyst Marie Thibault maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $185 to $170.
marketbeat.com What iRhythm Technologies (IRTC) Said on Its Q3 Earnings Call iRhythm Technologies NASDAQ: IRTC raised its 2026 revenue and profitability outlook after reporting third-quarter growth driven by its core Zio monitor business, even as demand for its Zio AT…
seekingalpha.com iRhythm Holdings, Inc. (IRTC) Q3 2026 Earnings Call Transcript iRhythm Holdings, Inc. (IRTC) Q3 2026 Earnings Call Transcript
zacks.com iRhythm Holdings, Inc. (IRTC) Q3 Earnings Surpass Estimates iRhythm Holdings, Inc. (IRTC) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.06 per share a year ago.
benzinga.com iRhythm Technologies Q3 2026 Earnings Call Transcript iRhythm Technologies (NASDAQ:IRTC) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…- benzinga.com iRhythm Holdings Raises FY2026 Sales Guidance from $880.000M-$890.000M to $890.000M-$895.000M vs $890.076M Est iRhythm Holdings (NASDAQ:IRTC) raises FY2026 sales outlook from $880.000 million-$890.000 million to $890.000 million-$895.000 million vs $890.076 million estimate.
- benzinga.com iRhythm Technologies Q3 Adj. EPS $0.82 Beats $0.06 Estimate, Sales $221.592M Miss $222.451M Estimate iRhythm Technologies (NASDAQ:IRTC) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.06 by 1266.67 percent. This is a 1466.67 percent increase over losses…
globenewswire.com iRhythm Holdings Announces Third Quarter 2026 Financial Results SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and…
benzinga.com This Urban Outfitters Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Analysts initiated coverage: ELAN Buy/$32, IRTC Overweight/$160, BAND Equal-Weight/$56, HRTG Market Perform, and URBN Buy/$100.- benzinga.com Piper Sandler Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160 Piper Sandler analyst Adam Maeder initiates coverage on iRhythm Holdings (NASDAQ:IRTC) with a Overweight rating and announces Price Target of $160.
- benzinga.com Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $150 Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $168 to $150.
benzinga.com Needham Maintains Buy on iRhythm Holdings, Raises Price Target to $194 Needham analyst David Saxon maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the price target from $192 to $194.- benzinga.com iRhythm Holdings Issues Update On Cybersecurity Incident Previously Disclosed in June 2026; Continues To Believe Incident Not Expected To Have Material Impact On Co's Financial Condition iRhythm Holdings, Inc. (NASDAQ:IRTC) today provided an update regarding the cybersecurity incident previously disclosed in June 2026. Following completion of the forensic investigation and subsequent…
- benzinga.com Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168 Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $180 to $168.
benzinga.com Truist Securities Maintains Buy on iRhythm Holdings, Raises Price Target to $168 Truist Securities analyst Richard Newitter maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the price target from $160 to $168.
benzinga.com iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care iRhythm to acquire VitalConnect for $287.5 million, expands cardiac monitoring portfolio after Q2 earnings beat and higher fiscal 2026 guidance.- benzinga.com Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168 Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $180 to $168.
- benzinga.com Needham Maintains Buy on iRhythm Holdings, Lowers Price Target to $192 Needham analyst David Saxon maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $255 to $192.
- benzinga.com Evercore ISI Group Maintains Outperform on iRhythm Holdings, Raises Price Target to $165 Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and raises the price target from $150 to $165.
- benzinga.com iRhythm To Acquire Maker Of Wearable Biosensor And Ambulatory Cardiac Monitoring Technology Vital Connect For ~$237.5M In Cash And ~$50M In IRTC Stock Upon closing, the transaction is expected to immediately expand iRhythm's addressable market and advance its evolution into a broader cardiac monitoring and intelligence platform. VitalConnect…
- benzinga.com iRhythm Holdings Raises FY2026 Sales Guidance from $875.000M-$885.000M to $880.000M-$890.000M vs $881.129M Est iRhythm Holdings (NASDAQ:IRTC) raises FY2026 sales outlook from $875.000 million-$885.000 million to $880.000 million-$890.000 million vs $881.129 million estimate.
- benzinga.com iRhythm Technologies Q2 Adj. EPS $0.58 Beats $(0.00) Estimate, Sales $224.172M Beat $219.324M Estimate iRhythm Technologies (NASDAQ:IRTC) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $(0.00) by Infinity percent. This is a 281.25 percent increase over…
- benzinga.com Stephens & Co. Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160 Stephens & Co. analyst Mason Carrico initiates coverage on iRhythm Holdings (NASDAQ:IRTC) with a Overweight rating and announces Price Target of $160.
- benzinga.com Truist Securities Maintains Buy on iRhythm Holdings, Lowers Price Target to $160 Truist Securities analyst Richard Newitter maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $174 to $160.
benzinga.com Evercore ISI Group Maintains Outperform on iRhythm Holdings, Lowers Price Target to $150 Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and lowers the price target from $160 to $150.- benzinga.com BTIG Reiterates Buy on iRhythm Holdings, Maintains $185 Price Target BTIG analyst Marie Thibault reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy and maintains $185 price target.
benzinga.com Top 3 Health Care Stocks You'll Regret Missing In Q2 Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold, according to Benzinga Pro. iRhythm, Procept Biorobotics, Anbio Biotechnology among lowest RSI values.
benzinga.com iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive Data iRhythm says hackers stole patient and proprietary data from third-party apps but sees no material impact on operations or finances.- benzinga.com iRhythm Reports Material Cybersecurity Incident Involving Exfiltration Of Patient And Corporate Data From Third-Party Applications Following Social Engineering Attack Material Cybersecurity Incidents. On June 8, 2026, iRhythm Holdings, Inc. (the "Company") identified unauthorized activity involving data maintained on certain third-party-hosted business…
- benzinga.com BTIG Reiterates Buy on iRhythm Holdings, Maintains $185 Price Target BTIG analyst Marie Thibault reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy and maintains $185 price target.
- benzinga.com iRhythm Technologies Settles Class Action Securities Litigation With $45M Payment For Dismissal With Prejudice On June 3, 2026, iRhythm Technologies, Inc. ("iRhythm Tech"), a wholly owned subsidiary of iRhythm Holdings, Inc. (the "Company"), entered into a binding Stipulation and Agreement of Settlement (the…
- benzinga.com Canaccord Genuity Maintains Buy on iRhythm Holdings, Lowers Price Target to $152 Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $180 to $152.
- benzinga.com B of A Securities Maintains Buy on iRhythm Holdings, Lowers Price Target to $180 B of A Securities analyst Stephanie Piazzola maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $225 to $180.
- benzinga.com Citigroup Maintains Buy on iRhythm Holdings, Raises Price Target to $157 Citigroup analyst Joanne Wuensch maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the price target from $155 to $157.
- benzinga.com Canaccord Genuity Maintains Buy on iRhythm Holdings, Lowers Price Target to $180 Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $198 to $180.
- benzinga.com JP Morgan Maintains Overweight on iRhythm Holdings, Lowers Price Target to $175 JP Morgan analyst Allen Gong maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $215 to $175.
- benzinga.com Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $180 Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $200 to $180.
- benzinga.com Evercore ISI Group Maintains Outperform on iRhythm Holdings, Lowers Price Target to $160 Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and lowers the price target from $170 to $160.